Efficacy And Safety Of Simtuzumab For The Treatment Of Primary Sclerosing Cholangitis: Results Of A Phase 2b, Dose-Ranging, Randomized, Placebo-Controlled TrialAndrew J. Muir,Z. Goodman,Cynthia Levy,Harry L.A. Janssen,Aldo J. Montano-Loza,Christopher L. Bowlus,D. Ding,C. Jia,B. Mccolgan,Robert P. Myers,M. Subramanian,John G. McHutchison,Michael P. Manns,Roger W. Chapman,Nezam H. Afdhal,Bertus EksteenJOURNAL OF HEPATOLOGY（2017）引用 13|浏览16暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
